0000879169-24-000032.txt : 20240122
0000879169-24-000032.hdr.sgml : 20240122
20240122130341
ACCESSION NUMBER: 0000879169-24-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240118
FILED AS OF DATE: 20240122
DATE AS OF CHANGE: 20240122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dickinson Jonathan Elliott
CENTRAL INDEX KEY: 0001780561
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 24547925
MAIL ADDRESS:
STREET 1: CARE OF INCYTE CORPORATION
STREET 2: 1801 AUGUSTINE CUT OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
wk-form4_1705946612.xml
FORM 4
X0508
4
2024-01-18
0
0000879169
INCYTE CORP
INCY
0001780561
Dickinson Jonathan Elliott
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, General Manager, Europe
0
Common Stock
2024-01-18
4
A
0
8114
61.18
A
44610
D
Common Stock
2024-01-19
4
F
0
122
61.49
D
44488
D
Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Including the information reported in this form, this includes an aggregate of 22,809 shares of common stock issuable pursuant to previously reported restricted stock units that have not
vested.
/s/ Elizabeth Feeney, Attorney-In-Fact
2024-01-22